WashU Medicine Gynecologic Oncology
Information
Location:
Contact:
Map
When a woman receives a diagnosis of gynecologic cancer, she wants compassionate, experienced specialists by her side. WashU Medicine Gynecologic Oncology provides the highest-quality individualized care to women diagnosed with gynecologic malignancies and those with suspected gynecologic cancer or precancerous conditions. This includes women who have cancer of the cervix, endometrium, fallopian tubes, ovaries, uterus, vagina, and vulva. This cross-specialty team includes gynecologic oncologists, radiation oncologists, pathologists, nurse practitioners, and nurse coordinators.
Comprehensive Treatment Options: The team works with the patient to develop a targeted treatment plan to address their specific cancer. Options include, but are not limited to, chemotherapy, radiation therapy, immunotherapy, minimally invasive gynecologic surgery, robot-assisted gynecologic surgery (da Vinci® System), and fertility-sparing options. Patients who have received their primary treatment elsewhere are welcomed to the practice to evaluate next steps and a variety of advanced treatment options.
Knowledge and Compassion in an Inclusive Practice: The physicians offer full continuity of care, from diagnosis and surgery to treatment and therapy. The team assists in the initial decision-making process, offers support groups and counseling services, and continues care beyond treatment, including follow-up and long-term care.
Clinical Trials: As part of Siteman Cancer Center, one of the nation’s top cancer treatment and research centers, the specialists offer 20 gynecologic oncology clinical trials. This means that eligible patients may have the opportunity to receive innovative new cancer treatments that would otherwise not be available to them.
When fighting gynecologic cancer, dedicated support and specialized experience can mean a distinct survival advantage. WashU Medicine Gynecologic Oncology offers both.
WashU Medicine Gynecologic Oncology is proud to offer clinical trials directed to specific protein abnormalities in the tumor microenvironment. This personalized care can offer novel therapies earlier than standard of care in the surrounding community.
Multiple Locations
4921 Parkview Place, St. Louis, MO 63110
3023 N. Ballas Road, St. Louis, MO 63131
150 Entrance Way, St. Peters, MO 63376